943 F.3d 953
D.C. Cir.2019Background
- Medicaid manufacturers must self-report Average Manufacturer Price (AMP) quarterly; rebates and additional inflation-based rebates are calculated from AMP, and civil penalties (up to $100,000 per item) apply for knowingly providing false information.
- Ipsen manufactured Somatuline Depot (introduced 2007) and, after new FDA approval in 2014 for Somatuline ED, notified CMS and reported a new base-date AMP for Somatuline ED.
- CMS responded months later rejecting Ipsen’s entitlement to a new base-date AMP and instructed that Somatuline ED’s baseline must reflect the original Somatuline Depot baseline; a follow-up letter from CMS’s Pharmacy Division Director repeated that position and stated it was not a final agency action.
- Ipsen sued, arguing the CMS letters were final agency action subject to APA review; CMS moved for summary judgment that no final agency action occurred.
- The district court granted summary judgment to CMS; Ipsen appealed to the D.C. Circuit challenging whether the letters satisfy Bennett v. Spear’s second prong (legal consequences).
- The D.C. Circuit reversed, holding Ipsen plausibly showed the letters caused legal consequences by increasing the risk of enhanced penalties for "knowing" false reporting, and remanded for further proceedings.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether CMS’s letters are "final agency action" under Bennett prong two (i.e., whether legal consequences flow from the letters) | Letters increased Ipsen’s risk of future civil penalties for "knowingly" providing false information and thus produced legal consequences sufficient for review | Letters were non-final guidance/advice (Director said not final); not an authoritative statement triggering willfulness penalties; any penalty depends on later enforcement | The letters are final: they meaningfully increased penalty risk by applying law to Ipsen’s facts, operate in a self-reporting regime where risk accrues each quarter, and leave Ipsen no other review route; reversed and remanded |
Key Cases Cited
- Bennett v. Spear, 520 U.S. 154 (two-part test for final agency action)
- Sackett v. EPA, 566 U.S. 120 (agency order created legal consequences by increasing future penalties)
- U.S. Army Corps of Eng’rs v. Hawkes Co., 136 S. Ct. 1807 (pragmatic inquiry into legal consequences)
- Rhea Lana, Inc. v. DOL, 824 F.3d 1023 (agency letter created risk of willfulness penalties; applied Sackett)
- Soundboard Ass’n v. FTC, 888 F.3d 1261 (distinguishing non-final staff letter)
- Safeco Ins. Co. of Am. v. Burr, 551 U.S. 47 (authoritative guidance can warn regulated parties away from a reasonable interpretation)
- U.S. ex rel. Purcell v. MWI Corp., 807 F.3d 281 (informal guidance insufficient to establish knowing falsity)
- Southwest Airlines Co. v. U.S. Dep’t of Transp., 832 F.3d 270 (individual adjudication as final agency action)